$HSTM

HEALTHSTREAM INC (HSTM): Results of Operations and Financial Condition

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_967176.htm EXHIBIT 99.1 ex_967176.htm HealthStream Announces Second Quarter 2026 Results Page 1 August 3, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Com

Original reporting
Published Aug 3, 2026, 8:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HSTM
Bullish
high confidence
Mentioned
$HSTM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HSTMBullishHigh
01

Why it matters

Traders can update models immediately using the disclosed Q2 performance and the revised 2026 ranges, and reassess near-term expectations for revenue growth, profitability, and cash generation.

02

Market read

Company-specific earnings and guidance update with explicit financial ranges and a declared quarterly dividend.

03

What to watch

Watch the mix shift between subscription and professional services, and whether higher cloud hosting, royalties, and commissions expenses persist into the back half of 2026.

Relevance 7/10Novelty 9/10Timing: after-hours filing of Q2 results and 2026 guidance update (Aug 3, 2026)

Background

The filing is an SEC 8-K Item 2.02 with Exhibit 99.1 announcing HealthStream’s second quarter 2026 results and providing updated full-year 2026 guidance.

Company-level read

Ticker impact

$HSTMBullishHigh confidence
Context

HealthStream reported Q2 2026 results and updated full-year 2026 guidance, including revenue, net income, and Adjusted EBITDA ranges.

Expected impact

Likely positive bias for the next session and into guidance digestion, with volatility around whether investors focus on subscription growth, margin drivers, or the guidance midpoint.

Evidence & confidence

The filing discloses specific Q2 financials (revenue, operating income, net income, EPS, Adjusted EBITDA) and provides updated 2026 guidance ranges, which are actionable inputs for earnings-model updates.

Market effects

Healthcare clinical workforce technology names may see read-across from HealthStream’s subscription growth and margin trajectory.

Primarily impacts US Nasdaq healthcare IT sentiment; limited direct regional spillover beyond healthcare software/IT.

Low global relevance; the disclosure is company-specific with no stated international regulatory or macro linkage.

Counterpoint

Investors may discount the operating income improvement if it is heavily influenced by sublease income and one-time variable consideration catch-up under ASC 606.

Key entities

  • HealthStream, Inc.

    Nasdaq-listed healthcare technology platform company reporting Q2 2026 results and updating 2026 guidance.

  • Virsys12

    Acquisition referenced as contributing $3.1 million to Q2 2026 revenue growth versus Q2 2025.

  • MissionCare Collective

    Acquisition referenced as contributing to Q2 2026 revenue growth versus Q2 2025.

Related articles

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.